This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
with Joachim Rudolph New drugs are discovered by teams, not individuals. "Drug discovery is a complex undertaking, and I enjoy…
Article
2 years ago ●
2 mins read
Context. ICeD-2 (Merck) is a dipeptidyl peptidase 9 (DPP9) inhibitor under development for HIV-1 infections. Despite the significant advancements in…
molecule
11 months ago ●
4 mins read
Announcement: Appointment of Drug Hunter Advisory Board Member: Wendy Young, Ph. D. Drug Hunter is pleased to introduce a new member of our…
Article
2 years ago ●
3 mins read
Context. GB1211 (Galecto Biotech) is an oral galectin-3 inhibitor under development for fibrotic disease. First described in 1971, galectin-3, a…
molecule
11 months ago ●
5 mins read
Announcement: Appointment of Drug Hunter Advisory Board Member: Andrew Setikas Drug Hunter is pleased to introduce a new member of our Advisory Board,…
Article
2 years ago ●
3 mins read
Context. GST-HG131 (WuXi AppTec) is an oral hepatitis B virus (HBV) inhibitor which lowers hepatitis B antigen (HBsAg) levels which…
molecule
11 months ago ●
5 mins read
Load More
